A clinical trial to study the effect of kushmanand beej churn and satvavajaya chikitsa in the patient having sign and symptoms of dhee dhriti and smriti ( manas rog)

Phase 2

Not yet recruiting

• Conditions: Other psychoactive substance related disorders,

• Registration Number: CTRI/2019/12/022259
• Lead Sponsor: NATIOINAL INSTITUTE OF AYURVEDA JAIPUR

Brief Summary

This is open label randomised single centre comparing efficacy of ayurvedic drug kushmand beej and kushmand beej ,satvavajaya chikitsa  in the management of dhee, dhriti, smriti (mild coginitive impairment). Patients of both sexes age of 18 years and above of dhee dhriti smriti  will be selected for relieving sign and symptoms. 60 clinically diagnoded and confirmed patients will be divided into two groups for administration of trial drug. In group A  30 patients will be administered trial drug kushmand beej in the dose of 6 gm BD orally for 60 days . In group B  30 patients will be administered trial drug kushmand beej as well as witrh satvavajaya chikitsa for 60 days . All the patients registered for clinical trial will be asked for any changes in their clinical manifestation and growing feeling of well being. conclusion - To compare the efficacy of both the groups.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-05-12
• Last Update Posted: 2019-11-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

The Individuals having the all age group more than 18 years with impairment of Dhee, Dhriti and Smriti.

Exclusion Criteria

Schizophrenia, Parkinsonism, Dementia, Alzheimer, Uremia, Encephalopathy preganant women, lactating mother and any major systemic disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
patients of both sexes age group above 18 years of dhee dhriti smriti will be selected for reliving sign and symptoms	patients of both sexes age group above 18 years of dhee dhriti smriti will be selected for reliving sign and symptoms

Secondary Outcome Measures

Name	Time	Method
asses the comparative efficacy between both groups after 8 weeks in case of dhee dhriti and smriti impairment.	asses the comparative efficacy between both groups after 8 weeks in case of dhee dhriti and smriti impairment

Trial Locations

Locations (1)

NATIOINAL INSTITUTE OF AYURVEDA HOSPITAL JAIPUR; 🇮🇳 Jaipur, RAJASTHAN, India

NATIOINAL INSTITUTE OF AYURVEDA HOSPITAL JAIPUR

🇮🇳Jaipur, RAJASTHAN, India

ANSHU SHARMA

Principal investigator

8890233668

anshusharma6668@gmail.com